1
|
Zhou X, Zhu Z, Tu H, Liu D, Cao C, Xu J, Li S. [Interpretation of the Action Plan to Accelerate the Elimination of Schistosomiasis in China (2023- 2030)]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2024; 36:7-12. [PMID: 38604679 DOI: 10.16250/j.32.1374.2023161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/13/2024]
Abstract
On June 16, 2023, National Disease Control and Prevention Administration of the People's Republic of China, in collaboration with other ministries, formulated and issued the Action Plan to Accelerate the Elimination of Schistosomiasis in China (2023-2030). The implementation of this plan provides an important basis for achieving the targets set in the "Healthy China 2030" action plan and the implementation of the rural revitalization strategy. This paper describes the background, principles, targets, control strategies, safeguard measures and effectiveness evaluation of the plan, in order to guide the scientific and standardized implementation of actions for schistosomiasis elimination at the grassroots level, and facilitate the progress towards elimination of schistosomiasis in China with a high quality.
Collapse
Affiliation(s)
- X Zhou
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
| | - Z Zhu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
| | - H Tu
- Bureau of Health and Immunization Programmes, National Disease Control and Prevention Administration, China
| | - D Liu
- Bureau of Health and Immunization Programmes, National Disease Control and Prevention Administration, China
| | - C Cao
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
| | - J Xu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
| | - S Li
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
| |
Collapse
|
2
|
Tu H, Li S, Liu C, Luo Z, Ni L, Zhang Y, Deng W, Zou G, Zhou L, Hou H, Ji X. Difluoroethylene Carbonate as an Electrolyte Additive for Engineering the Electrolyte-Electrode Interphase of Lithium Metal Batteries. ACS Appl Mater Interfaces 2023; 15:53533-53539. [PMID: 37938031 DOI: 10.1021/acsami.3c13096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2023]
Abstract
Difluoroethylene carbonate (DFEC) featuring abundant fluorine atoms has been proposed as a multifunctional electrolyte additive to boost the stability of the electrolyte-electrode interphase of lithium metal batteries. Thus, introducing the DFEC additive enables a high capacity retention rate of the Li||NCM811 full cell (up to 75% after 200 cycles) at 4.5 V high voltage.
Collapse
Affiliation(s)
- Hanyu Tu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Shuo Li
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Chang Liu
- School of Chemistry and Chemical Engineering, Hunan Institute of Engineering, Xiangtan 411104, China
| | - Zheng Luo
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Lianshan Ni
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Yinghao Zhang
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Wentao Deng
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Guoqiang Zou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Liangjun Zhou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Hongshuai Hou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Xiaobo Ji
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| |
Collapse
|
3
|
Xu L, Li S, Tu H, Zhu F, Liu H, Deng W, Hu J, Zou G, Hou H, Ji X. Molecular Engineering of Highly Fluorinated Carbon Dots: Tailoring Li + Dynamics and Interfacial Fluorination for Stable Solid Lithium Batteries. ACS Nano 2023; 17:22082-22094. [PMID: 37916798 DOI: 10.1021/acsnano.3c08935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2023]
Abstract
Fluorinated carbon dots (FCDs) have garnered interest owing to their distinct physicochemical properties. Nevertheless, intricate synthesis procedures and quite low fluorine doping levels limit its development and application. Herein, we propose a facile approach based on the Claisen-Schmidt reaction to realize gram-scale synthesis of highly fluorinated carbon dots (up to 20.79 at. %) at room temperature and atmospheric pressure, and a comprehensive exploration of the specific reaction mechanism is conducted. Furthermore, in consideration of the high fluorine content, good dispersibility, and compatibility with polymer electrolyte, the synthesized FCDs are utilized as an additive for PEO-based solid electrolytes of a Li battery to improve its ionic conductivity, interface stability, and mechanical properties. The introduction of FCDs can not only reduce the crystallinity of PEO and enhance the interaction of polymer chains, but also facilitate the establishment of uninterrupted pathways and in situ fluorination at the interface, which is substantiated by both theoretical calculations and experimental findings. As a result, the lithium symmetrical battery can operate stably for 1000 h at a current density of 0.4 mA cm-2. Simultaneously, the LiFePO4/Li battery utilizing the composite electrolyte exhibits a capacity of 130.3 mAh g-1 over 300 cycles while maintaining a capacity retention rate of 95.10%. This study develops a strategy for synthesizing highly fluorinated carbon dots, which demonstrate a useful influence on PEO electrolytes, thus boosting the advancement of FCDs and solid-state batteries.
Collapse
Affiliation(s)
- Laiqiang Xu
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
- College of Materials Science and Engineering, Central South University of Forestry and Technology, Changsha 410004, China
| | - Shuo Li
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Hanyu Tu
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Fangjun Zhu
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Huaxin Liu
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Wentao Deng
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Jinbo Hu
- College of Materials Science and Engineering, Central South University of Forestry and Technology, Changsha 410004, China
| | - Guoqiang Zou
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Hongshuai Hou
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Xiaobo Ji
- College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| |
Collapse
|
4
|
Tu H, Liu H, Xu L, Luo Z, Li L, Tian Y, Deng W, Zou G, Hou H, Ji X. Carbon dots from alcohol molecules: principles and the reaction mechanism. Chem Sci 2023; 14:12194-12204. [PMID: 37969573 PMCID: PMC10631255 DOI: 10.1039/d3sc04606k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Accepted: 10/09/2023] [Indexed: 11/17/2023] Open
Abstract
Carbon dots (CDs) have attracted significant attention in the energy, environment, and biology fields due to their exceptional physicochemical properties. However, owing to the multifarious precursors and complex reaction mechanisms, the production of carbon dots from organic molecules is still a mysterious process. Inspired by the color change of sodium hydroxide ethanol solution after standing for some time, in this work, we thoroughly investigated the reaction mechanism from alcohol molecules to carbon dots through a lot of experiments and theoretical calculations, and it was found that the rate-controlling reaction is the formation of aldehydes, and it is also confirmed that there is a self-catalysis reaction, which can accelerate the conversion from alcohol to aldehyde, further facilitating the final formation of CDs. After the rate-controlling reaction of alcohol to aldehyde, under strongly alkaline conditions, an aldol reaction occurs to form unsaturated aldehydes, followed by further condensation and polymerization reactions to form long carbon chains, which are cross-linked and dehydrated to form carbon dots with a carbon core and surface functional groups. Additionally, it is found that the reaction can be largely accelerated with the assistance of electricity, which indicates the great prospect of industrial production. Furthermore, the obtained CDs with rich functional groups can be utilized as electrolyte additives to optimize the deposition behavior of Na metal, manifesting great potential towards safe and stable Na metal batteries.
Collapse
Affiliation(s)
- Hanyu Tu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Huaxin Liu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Laiqiang Xu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Zheng Luo
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Lin Li
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Ye Tian
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Wentao Deng
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Guoqiang Zou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Hongshuai Hou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| | - Xiaobo Ji
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University Changsha 410083 China
| |
Collapse
|
5
|
Xu L, Xiao X, Tu H, Zhu F, Wang J, Liu H, Huang W, Deng W, Hou H, Liu T, Ji X, Amine K, Zou G. Engineering Functionalized 2D Metal-Organic Frameworks Nanosheets with Fast Li + Conduction for Advanced Solid Li Batteries. Adv Mater 2023; 35:e2303193. [PMID: 37267091 DOI: 10.1002/adma.202303193] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 05/17/2023] [Indexed: 06/04/2023]
Abstract
Solid-state batteries can ensure high energy density and safety in lithium metal batteries, while polymer electrolytes are plagued by slow ion kinetics and low selective transport of Li+ . Metal-organic frameworks (MOFs) are proposed as emerging fillers for solid-state poly(ethylene oxide)(PEO) electrolytes, however, developing functionalized MOFs and understanding their roles on ion transfer has proven challenging. Herein, combining computational and experimental results, the functional group regulation in MOFs can effectively change surficial charge distribution and limit anion movement is revealed, providing a potential solution to these issues. Specifically, functionalized 2D MOF sheets are designed through molecular engineering to construct high-performance composite electrolytes, where the electron-donating effect of substituents in 2D-MOFs effectively limits the movement of ClO4 - and promotes mechanical properties and ion migration numbers (0.36 up to 0.64) of PEO. As a result, Li/Li cells with composite electrolyte exhibit superior cyclability for 1000 h at a current density of 0.2 mA cm-2 . Meanwhile, the solid LiFePO4 /Li battery delivers highly reversible capacities of 148.8 mAh g-1 after 200 cycles. These findings highlight a new approach for anion confinement through the use of functional group electronic effects, leading to enhanced ionic conductivity, and a feasible direction for high-performance solid-state batteries.
Collapse
Affiliation(s)
- Laiqiang Xu
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
- College of Materials Science and Engineering, Central South University of Forestry and Technology, Changsha, 410004, China
| | - Xuhuan Xiao
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Hanyu Tu
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Fangjun Zhu
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Jing Wang
- Chemical Sciences and Engineering Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Huaxin Liu
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Weiyuan Huang
- Chemical Sciences and Engineering Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Wentao Deng
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Hongshuai Hou
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Tongchao Liu
- Chemical Sciences and Engineering Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Xiaobo Ji
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
- College of Materials Science and Engineering, Central South University of Forestry and Technology, Changsha, 410004, China
| | - Khalil Amine
- Chemical Sciences and Engineering Division, Argonne National Laboratory, Lemont, IL, 60439, USA
| | - Guoqiang Zou
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| |
Collapse
|
6
|
Liu H, Xu L, Tu H, Luo Z, Zhu F, Deng W, Zou G, Hou H, Ji X. Interfacial Interaction of Multifunctional GQDs Reinforcing Polymer Electrolytes For All-Solid-State Li Battery. Small 2023; 19:e2301275. [PMID: 37081376 DOI: 10.1002/smll.202301275] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Revised: 03/07/2023] [Indexed: 05/03/2023]
Abstract
Solid-state polymer electrolytes are highly anticipated for next generation lithium ion batteries with enhanced safety and energy density. However, a major disadvantage of polymer electrolytes is their low ionic conductivity at room temperature. In order to enhance the ionic conductivity, here, graphene quantum dots (GQDs) are employed to improve the poly (ethylene oxide) (PEO) based electrolyte. Owing to the increased amorphous areas of PEO and mobility of Li+ , GQDs modified composite polymer electrolytes achieved high ionic conductivity and favorable lithium ion transference numbers. Significantly, the abundant hydroxyl groups and amino groups originated from GQDs can serve as Lewis base sites and interact with lithium ions, thus promoting the dissociation of lithium salts and providing more ion pathways. Moreover, lithium dendrite is suppressed, associated with high transference number, enhanced mechanical properties and steady interface stability. It is further observed that all solid-state lithium batteries assembled with GQDs modified composite polymer electrolytes display excellent rate performance and cycling stability.
Collapse
Affiliation(s)
- Huaxin Liu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Laiqiang Xu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Hanyu Tu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Zheng Luo
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Fangjun Zhu
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Wentao Deng
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Guoqiang Zou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Hongshuai Hou
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| | - Xiaobo Ji
- State Key Laboratory of Powder Metallurgy, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China
| |
Collapse
|
7
|
Wu J, Liu C, Zhang H, Ge Z, Tu H, Deng W, Hou H, Ji X. Regulation of the Electrochemical Plating/Stripping Process for Zn: Multifunctional Effects of N, S-Codoped Carbon Dots. J Phys Chem Lett 2022; 13:11883-11891. [PMID: 36524766 DOI: 10.1021/acs.jpclett.2c03502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
The aqueous zinc-ion battery is considered as one of the best alternatives to lithium-ion batteries due to its low cost and high safety. However, the inevitable dendrite growth, byproduct formation, and the side reactions have inhibited the application of aqueous zinc-ion batteries. In this work, the electronegative nitrogen and sulfur-codoped carbon dots (NSCDs) are proposed as an electrolyte additive to regulate the uniform distribution of zinc ions and inhibit the growth of dendrites. It was found that only a small amount of NSCD additive (0.2 mg mL-1) exerted a significant influence in electrochemical performance; the symmetrical cell can operate stably for 2000 h with a low voltage hysteresis of 33 mV at the current density of 1 mA cm-2, and a high Coulombic efficiency (CE) of 99.5% can be obtained after 250 cycles.
Collapse
Affiliation(s)
- Jiae Wu
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Chang Liu
- School of Chemistry and Chemical Engineering, Hunan Institute of Engineering, Xiangtan 411104, China
| | - Hao Zhang
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Zhaofei Ge
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Hanyu Tu
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Wentao Deng
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Hongshuai Hou
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Xiaobo Ji
- Key Laboratory of Hunan Province for Chemical Power Source, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| |
Collapse
|
8
|
Liu SY, Dong S, Liao RQ, Jiang B, Zhang JT, Lin JT, Zhang S, Yang J, Nie Q, Yang X, Wang Q, Yan HH, Yan L, Tu H, Wang BC, Yang JJ, Zhou Q, Liu SY, Zhong WZ, Wu YL. LBA2 Phase II study of PD-L1 expression guidance on neoadjuvant (NA) nivolumab (Nivo) monotherapy with or without platinum-doublet chemotherapy in resectable NSCLC. Immuno-Oncology and Technology 2022. [DOI: 10.1016/j.iotech.2022.100363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
9
|
Tu H, Wang Y, Sui J, Li D, Shi X, Li G, Luo Q, Lei Q, Wang C, Wang J, Yan J, Liu M, Lu H. Patient-Derived Oral Squamous Cell Carcinoma Organoids for Predicting Tumoral Radiosensitivity. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
10
|
Lin E, Tu H, Hong C. 160 Halved incidence of scrub typhus after travel restriction to confine a surge of COVID-19 in Taiwan in 2021. J Invest Dermatol 2022. [PMCID: PMC9296970 DOI: 10.1016/j.jid.2022.05.167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
11
|
Tu H, Li S, Luo Z, Xu L, Zhang H, Xiang Y, Deng W, Zou G, Hou H, Ji X. Bi-doped carbon dots for a stable lithium metal anode. Chem Commun (Camb) 2022; 58:6449-6452. [PMID: 35552567 DOI: 10.1039/d2cc01334g] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Bi-doped carbon dots (Bi-CDs) with rich polar groups and good compatibility were employed as co-deposition electrolyte additives to homogenize Li+ flux for dendrite-free Li deposition. High coulombic efficiency (99.0%) and long-term stability (800 h) with reduced overpotential (∼15 mV) were achieved after introducing Bi-CDs in conventional electrolyte for high-performance Li-S batteries.
Collapse
Affiliation(s)
- Hanyu Tu
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Shuo Li
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Zheng Luo
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Laiqiang Xu
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Hao Zhang
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Yinger Xiang
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Wentao Deng
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Guoqiang Zou
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Hongshuai Hou
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China.
| | - Xiaobo Ji
- College of Chemistry and Chemical Engineering, Central South University, Changsha, China. .,School of Materials Science and Engineering, Zhengzhou University, Zhengzhou, 450001, China
| |
Collapse
|
12
|
Abstract
Mesenchymal stem cells (MSCs) are a promising therapy in regenerative medicine, but the clinical efficacy has yet to be identified, because the functions of MSCs are modulated by many factors, including the age and health condition of donors, origin of the tissue, and several other unknown factors. Recently, it has been revealed that, besides host factors, the microbiota that inhabits the human body is a modulator of MSCs as well. Here, we highlight the role of microbiota in the alteration of MSCs functions, with a specific focus on the self-renewal ability, multiple differentiation potential, and the immunomodulation capacity of MSCs. We also review the clinical trials and model research on the synergic and antagonistic effects of microbiota in stem cell therapy. In addition, we discuss the underlying mechanisms of the interplay between microbiota and MSCs, which are elucidated using omics approaches followed by verification experiments. As oral and maxillofacial tissues are important sources of MSCs, as well as a major access to diverse microbes, further studies are needed to elucidate these interactions in the oral field to make greater advancements in regenerative medicine.
Collapse
Affiliation(s)
- H Tu
- Hunan Key Laboratory of Oral Health Research and Human 3D Printing Engineering Research Central of Oral Care and Hunan Clinical Research Center of Oral Major Diseases and Oral Health and Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha City, Hunan Province, P.R. China
| | - E Xiao
- Beijing Maybio Pharmaceutical Biotechnology Development Co., Ltd., Changsha City, Hunan Province, P.R. China
| | - O Liu
- Hunan Key Laboratory of Oral Health Research and Human 3D Printing Engineering Research Central of Oral Care and Hunan Clinical Research Center of Oral Major Diseases and Oral Health and Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha City, Hunan Province, P.R. China
| |
Collapse
|
13
|
Zhang ZG, Pavon L, Tu H. Editorial: Novel Aspects of Neurotransmitters. Front Cell Dev Biol 2021; 9:800765. [PMID: 34869396 PMCID: PMC8637445 DOI: 10.3389/fcell.2021.800765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2021] [Accepted: 10/28/2021] [Indexed: 11/13/2022] Open
Affiliation(s)
- Z G Zhang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - L Pavon
- Laboratorio de Psicoinmunología, Dirección de Investigaciones en Neurociencias del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico
| | - H Tu
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
14
|
Zheng M, Li Y, Tu H, Sun H, Yin K, Yang J, Zhang X, Zhou Q, Wu Y. OA16.03 Matched Targeted Therapy by cfDNA of CSF Beyond Leptomeningeal Metastases Progression Upon Osimertinib in EGFR-Mutated NSCLC Patients. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Dong S, Wang Z, Zhou Q, Yang L, Zhang J, Chen Y, Liu S, Lin J, Liao R, Tu H, Xu C, Yang X, Zhong W, Yang J, Wu Y. P49.01 Drug Holiday Based on Minimal Residual Disease Status After Local Therapy Following EGFR-TKI Treatment for Patients With Advanced NSCLC. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.529] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
16
|
Liao R, Xu C, Yang X, Liu S, Zhong W, Tu H, Wang Z, Wu Y. P40.02 Pemetrexed in Advanced-stage Lymphoepithelioma Carcinoma of Lung. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Tu H, Tang LJ, Luo XJ, Ai KL, Peng J. Insights into the novel function of system Xc- in regulated cell death. Eur Rev Med Pharmacol Sci 2021; 25:1650-1662. [PMID: 33629335 DOI: 10.26355/eurrev_202102_24876] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
System Xc-, also named cystine/glutamate antiporter, is an important intracellular antioxidant element. It is composed of the light chain SLC7A11 (xCT) and the heavy chain SLC3A2 (4F2hc) and functions as raw materials for the synthesis of glutathione (GSH). Recent studies have demonstrated that system Xc- plays an important role in different types of regulated cell death, which is referred to cell death controlled by dedicated molecular machinery. It has been shown that system Xc- involves in ferroptosis, apoptosis, and autophagy-dependent cell death, contributing to different diseases and drug resistance, such as cancer, neurological disorders, and cisplatin resistance to cancers. To date, the intervention of system Xc- by its inhibitors or activators displays a beneficial effect on the treatment of certain diseases. In this review, we summarize recent findings on the role of system Xc- in regulated cell death, including molecular mechanisms and potential therapeutic applications.
Collapse
Affiliation(s)
- H Tu
- Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
| | | | | | | | | |
Collapse
|
18
|
Chen J, Wei W, Zheng L, Li H, Feng Y, Wan T, Huang Q, Liu G, Tu H, Qiu J, Jiang X, Xiong Y, Zheng M, Li J, Huang H, Song L, Liu J, Zhang Y. 732P Anlotinib plus pemetrexed in patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
19
|
Peng L, Li A, Liu S, Sun H, Zheng M, Zhou J, Zhang J, Zhang X, Zhou Q, Zhong W, Yang X, Tu H, Su J, Yan H, Gou L, Gao H, Wu Y. P85.02 NGS could not Replace FISH Regarding to MET Amplification as an Optimal Biomarker. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Shi M, Gu A, Tu H, Huang C, Wang H, Yu Z, Wang X, Cao L, Shu Y, Wang H, Yang R, Li X, Chang J, Hu Y, Shen P, Hu Y, Guo Z, Tao M, Zhang Y, Liu X, Sun Q, Zhang X, Jiang Z, Zhao J, Chen F, Yu H, Zhang W, Sun J, Li D, Zhou J, Han B, Wu YL. Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial. Ann Oncol 2020; 32:85-96. [PMID: 33130217 DOI: 10.1016/j.annonc.2020.10.479] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 09/25/2020] [Accepted: 10/15/2020] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND Polymeric micellar paclitaxel (pm-Pac) is a novel Cremophor EL-free, nanoparticle micellar formulation of paclitaxel. We aimed to compare the efficacy and safety between pm-Pac plus cisplatin and solvent-based paclitaxel (sb-Pac) plus cisplatin in advanced non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS A total of 448 stage IIIB to IV NSCLC patients were randomly assigned (2:1) to receive six 3-week cycles of either pm-Pac (230 mg/m2) plus cisplatin (70 mg/m2; n = 300), followed by dose escalation of pm-Pac to 300 mg/m2 from the second 3-week cycle if prespecified toxic effects were not observed after the first cycle, or sb-Pac (175 mg/m2) plus cisplatin (70 mg/m2; n = 148). The primary end point was objective response rate (ORR) assessed by independent review committees (IRCs). The secondary end points included IRC-assessed progression-free survival (PFS), overall survival (OS), and safety. RESULTS Patients in the pm-Pac-plus-cisplatin group showed significant improvements in IRC-assessed ORR compared with those in the sb-Pac-plus-cisplatin group (50% versus 26%; rate ratio 1.91; P < 0.0001). Additionally, subgroup analysis showed that a higher ORR was consistently observed in both squamous and nonsquamous histological types. IRC-assessed median PFS was significantly higher in the pm-Pac-plus-cisplatin group than in the sb-Pac-plus-cisplatin group (6.4-month versus 5.3-month; hazard ratio 0.63; P = 0.0001). Median OS was not significantly different between the two groups. The incidence of treatment-related serious adverse events (9% versus 18%; P = 0.0090) was significantly lower in the pm-Pac-plus-cisplatin group than in the sb-Pac-plus-cisplatin group. CONCLUSION Pm-Pac plus cisplatin yielded superior ORR and PFS along with a favorable safety profile and should become an option for patients with advanced NSCLC. CLINICAL TRIAL IDENTIFIER ClinicalTrials.gov NCT02667743; https://clinicaltrials.gov/ct2/show/NCT02667743.
Collapse
Affiliation(s)
- M Shi
- Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
| | - A Gu
- Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - H Tu
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China
| | - C Huang
- Department of Thoracic Oncology, Fujian Cancer Hospital, The Affiliated Cancer Hospital of Fujian Medical University, Fuzhou, China
| | - H Wang
- Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
| | - Z Yu
- Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China
| | - X Wang
- Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, China
| | - L Cao
- Department of Pneumology, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Hefei, China
| | - Y Shu
- Department of Oncology, Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
| | - H Wang
- Department of Medical Oncology, Tianjin Union Medical Centre, Tianjin, China
| | - R Yang
- Department of Tumor Chemotherapy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Center, Kunming, China
| | - X Li
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Chang
- Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Y Hu
- Department of Medical Oncology, Hubei Cancer Hospital, Wuhan, China
| | - P Shen
- Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China
| | - Y Hu
- Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China
| | - Z Guo
- Department of Pneumology, Shanghai East Hospital, The Affiliated East Hospital of Tongji University, Shanghai, China
| | - M Tao
- Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China
| | - Y Zhang
- Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - X Liu
- Department of Medical Oncology, Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-Sen University, Shantou, China
| | - Q Sun
- Department of Medical Oncology, Henan Provincial Chest Hospital, Zhengzhou, China
| | - X Zhang
- Department of Pneumology, The Affiliated Zhongshan Hospital of Fudan University, Shanghai, China
| | - Z Jiang
- Department of Medical Oncology, Puyang Oilfield General Hospital, Puyang, China
| | - J Zhao
- Department of Medical Oncology, The Affiliated Hospital of Qinghai University, Xining, China
| | - F Chen
- School of Public Health, Nanjing Medical University, Nanjing, China
| | - H Yu
- School of Public Health, Nanjing Medical University, Nanjing, China
| | - W Zhang
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - J Sun
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - D Li
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - J Zhou
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - B Han
- Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
| | - Y L Wu
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
| |
Collapse
|
21
|
Aggarwal S, Whipple S, Hsu H, Tu H, Carrigan G, Wang X, Ngarmchamnanrith G, Chia V. 1339P Clinicopathological characteristics and treatment patterns observed in real-world care in patients with advanced non-small cell lung cancer (NSCLC) and KRAS G12C mutations in the Flatiron Health (FH)-Foundation Medicine (FMI) Clinico-Genomic Database (CGDB). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1653] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
22
|
Gottfried M, de Marinis F, Tu H, Laktionov K, Feng J, Poltoratskiy A, Zhao J, Tan EH, Lee V, Kowalski D, Yang CT, Srinivasa B, Passaro A, Clementi L, Tang W, Huang DL, Cseh A, Park K, Zhou C, Wu YL. Activity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz437.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Passaro A, De Marinis F, Tu H, Laktionov K, Feng J, Poltoratskiy A, Zhao J, Tan EH, Gottfried M, Lee V, Kowalski D, Yang CT, Srinivasa B, Clementi L, Tang W, Huang DL, Cseh A, Park K, Zhou C, Wu YL. Activity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz437.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
Tu H, Xu C, Tong-Li C, Offin M, Razavi P, Schapira E, Namakydoust A, Lee A, Pavlakis N, Clarke S, Diakos C, Chan D, Myers M, Makhnin A, Jain H, Martinez A, Iqbal Z, Adamski A, Li H, Hernandez J, Watford S, Hosseini A, Shaffer T, Lim L, Li M, Drilon A, Ladanyi M, Arcila M, Rusch V, Jones D, Rudin C, Rimner A, Isbell J, Li B. P1.01-122 A Clinical Utility Study of Plasma DNA Next Generation Sequencing Guided Treatment of Uncommon Drivers in Advanced Non-Small-Cell Lung Cancers. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.837] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
25
|
de Marinis F, Tu H, Laktionov K, Feng J, Poltoratskiy A, Zhao J, Egorova I, Tan EH, Gottfried M, Lee V, Kowalski D, Yang CT, Srinivasa B, Passaro A, Clementi L, Tang W, Huang DCL, Cseh A, Zhou C, Wu YL. A combined analysis of two phase IIIb studies of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz259.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
Zheng M, Li Y, Jiang B, Tu H, Ye J, Yang J, Zhang X, Chuai S, Sun H, Zhou Q, Zhong W, Wu Y. P2.01-88 Molecular Alterations in Cerebrospinal Fluid Predict Clinical Outcomes of Central Nervous System Metastases in Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
27
|
Wu Y, Tu H, Feng J, Shi M, Zhao J, Wang Y, Chang J, Wang J, Cheng Y, Zhu J, Tan E, Zhang Y, Lee V, Yang C, Su W, Lam D, Srinivasa B, Rajappa S, Ho C, Lam K, Hu Y, Bondarde S, Liu X, Pang K, Tian Y, Cseh A, Huang D, Zhou C. P2.01-99 A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Final Analysis. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1442] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Zhang C, Liu S, Su J, Gao X, Chang L, Guan Y, Tu H, Yang J, Zhang X, Zhong W. JCSE01.16 Metastatic Lymph Nodes as High Immunogenicity Media for Perioperative Immunotherapy in Locally Advanced NSCLC. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
29
|
Wu Y, Han B, Shi M, Tu H, Gu A, Huang C, Wang H, Yu Z, Wang X, Cao L, Shu Y, Wang H, Yang R, Li X, Chang J, Hu Y, Shen P, Hu Y, Guo Z, Tao M, Zhang Y, Liu X, Sun Q, Zhang X, Jiang Z, Zhao J, Chen F, Sun J, Li D, Zhou J. MA13.11 A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
30
|
Wagner C, Holmgren J, Sunstrum B, Tu H, Nadeau R. Associations with a Postoperative Opioid Prescription Following Third Molar Surgery. J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.joms.2019.06.160] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
31
|
Wu Y, Chang J, Zhang L, Tu H, Wu L, Feng J, Lu S, Zhou C, Wang J, Mok T, Taylor F, Mossman B, Penrod J, Lawrance R, Blum S, Wang P, Cheng Y. OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.10.020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Tang W, Zhang C, Lei Y, Fu R, Kang J, Yan H, Yang X, Tu H, Wu Y, Zhong W. P087 TNM Staging Inversely Correlates with Age in ALK-positive Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.10.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
33
|
Lu C, Tu H, Yan H, Zhang X, Wang B, Wang Z, Li A, Lin J, Li Y, Ke E, Song J, Chen S, Wang Y, Guan Y, Xia X, Yi X, Wu Y, Yang J.. P3.01-64 Preliminary Data of Diverse Therapies in Patients with Advanced Non–Small-Cell Lung Cancer Harbouring RET-Rearrangement. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
34
|
Wu Y, Tu H, Feng J, Shi M, Zhao J, Wang Y, Chang J, Wang J, Cheng Y, Zhu J, Tan E, Li K, Zhang Y, Lee V, Yang C, Su W, Lam D, Srinivasa B, Rajappa S, Ho C, Lam K, Hu Y, Bondarde S, Liu X, Huang D, Wang Y, Pang K, Zhou C. P1.01-98 A Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.654] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
35
|
Feng Y, Liu J, Huang H, Zhang C, Wan T, Tong C, Deng T, Tu H, Huang Y, Liu G, Huang Q, Liu Z. Comparison of PARPi with angiogenesis inhibitors and chemotherapy for maintenance in ovarian cancer: A network meta-analysis. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy285.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Su S, Dong Z, Zhi X, Su J, Chen Z, Yang J, Tu H, Zhou Q, Zhong W, Zhang X, Wu Y. MA15.01 Strong PD-L1 Expression Predicts Poor Response and de Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients with EGFR Mutation. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
37
|
Wu Y, Zhou Q, Zhang X, Tu H, Gan B, Wang B, Xu C, Chen H, Zheng M, Wang Z, Bai X, Sun Y, Myers A, Lv X, Chakraborti Y, Zhao S, Yang J., Callister J. JCSE01.09 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.217] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Jiang B, Li Y, Wu X, Hua B, Ding Y, Yang J., Zhang X, Yang X, Zhong W, Zhou Q, Tu H, Gao C, Wu S, Shao Y, Wu Y. P2.01-52 Identification of Leptomeningeal Metastasis-Specific Exosomal miRNA Signatures in Cerebrospinal Fluids of NSCLC Patients. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
39
|
Li Y, Jiang B, Zheng M, Tu H, Yang J., Zhang X, Ye J, Zhou Q, Zhong W, Zhang C, Chuai S, Wu Y. P1.01-55 Unique Genetic Profiles from Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC with Leptomeningeal Metastases. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Li M, Gan Y, Fan C, Yuan H, Zhang X, Shen Y, Wang Q, Meng Z, Xu D, Tu H. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies. J Viral Hepat 2018. [PMID: 29532605 DOI: 10.1111/jvh.12892] [Citation(s) in RCA: 59] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Previous studies have focused on the relationship between hepatitis B virus (HBV) infection and non-Hodgkin lymphoma (NHL). However, the results remain inconsistent and somehow conflicting in different subgroups. The aim of this study was to combine the findings of independent studies to comprehensively assess the association between HBV and NHL using a meta-analysis. Relevant studies were identified through structured keyword searches in PubMed, EMBASE and the China National Knowledge Infrastructure (CNKI) database, and 58 studies with a total of 53 714 NHL cases and 1 778 591 controls were finally included. Pooled estimates indicated a significantly increased NHL risk in HBV-infected individuals (summary odds ratio [sOR]: 2.50; 95% confidence interval [CI]: 2.20-2.83) regardless of the study design (case-control studies: sOR: 2.47; 95% CI: 2.16-2.82; cohort studies: sOR: 2.64; 95% CI: 1.78-3.91). Considerable heterogeneity was observed across studies that was primarily attributed to the NHL subtypes (meta-regression: P < .05). Overall, B-cell NHL (sOR: 2.46; 95% CI: 1.97-3.07) presented a stronger association with HBV infection than T-cell NHL (sOR: 1.67; 95% CI: 1.34-2.10). Within the B-cell NHL subtypes, HBV infection was significantly associated with diffuse large B-cell lymphoma (DLBCL, sOR: 2.06; 95% CI: 1.48-2.88) and follicular lymphoma (FL, sOR: 1.54; 95% CI: 1.11-2.12), but not with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) and Burkitt lymphoma. The results of this meta-analysis support a positive link between HBV infection and NHL development. Further investigations for the mechanisms underlying HBV-induced NHL are warranted.
Collapse
Affiliation(s)
- M Li
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Y Gan
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - C Fan
- Department of Etiology, Qidong People's Hospital/Qidong Liver Cancer Institute, Qidong, China
| | - H Yuan
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - X Zhang
- Shanghai Medical Insurance Affairs Management Center, Shanghai, China
| | - Y Shen
- Department of Head and Neck Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Q Wang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Z Meng
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - D Xu
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - H Tu
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
41
|
Tu H, Wan T, Gu H, Liu J. Sentinel lymph node biopsy combined with frozen section examination in cervical cancer: A single-institution pilot study. Gynecol Oncol 2018. [DOI: 10.1016/j.ygyno.2018.04.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Liang F, Sha CX, Fan CS, Chen WG, Tu H, Yang F, Cao GW, Qin HS. [Qidong Chronic Hepatitis B Cohort: participants enrollment and comparison of baseline characteristics by gender stratification]. Zhonghua Liu Xing Bing Xue Za Zhi 2018; 38:1569-1573. [PMID: 29141351 DOI: 10.3760/cma.j.issn.0254-6450.2017.11.026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To establish a study cohort of chronic hepatitis B (CHB) in Qidong and evaluate its baseline characteristics. Methods: CHB outpatients of the Third People's Hospital of Qidong were invited to participate in baseline survey from January 1, 2016, including questionnaire survey, liver function detection, serum detection of HBV infection and upper abdomen ultrasound detection. Anticipated sample size was at least one thousand. Baseline data were inputted by EpiData 3.1 software and then cleaned and analyzed by SAS 9.3 software. Results: As of 18 July, 2016, a total of 1 006 participants had been enrolled into the current study, including 615 males with an average age of (44.26±9.97) years and 391 females with an average age of (46.66±11.17) years. The difference in family history of liver disease was not significant between males and females (P>0.05), while the differences in other key information, such as age, education level, tobacco consumption, alcohol drinking, tea consumption, and antiviral intervention, were significant between males and females (P<0.05). Among the key clinical parameters, such as ALT, HBeAg, HBsAg, HBV DNA, albumin, and width of splenic vein and portal vein, only the abnormal rates of ALT and total bilirubin levels were higher in males than in females, the difference was significant (P<0.05). Conclusion: Outpatient department-based CHB cohort was established successfully in Qidong, and sub-cohort could be divided according to the differences on baseline characteristics.
Collapse
Affiliation(s)
- F Liang
- Department of Infectious Disease, Qidong Third People's Hospital, Qidong 226200, China
| | - C X Sha
- Department of Infectious Disease, Qidong Third People's Hospital, Qidong 226200, China
| | - C S Fan
- Department of Etiology, Qidong People's Hospital, Qidong 226200, China
| | - W G Chen
- Department of Infectious Disease, Qidong Third People's Hospital, Qidong 226200, China
| | - H Tu
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai 200032, China
| | - F Yang
- Department of Epidemiology, The Second Military Medical University, Shanghai 200433, China
| | - G W Cao
- Department of Epidemiology, The Second Military Medical University, Shanghai 200433, China
| | - H S Qin
- Deputy Director Office, Qidong County Health and Family Planning Commission, Qidong 226200, China
| |
Collapse
|
43
|
Zhang L, Ye Y, Tu H, Hildebrandt MA, Zhao L, Heymach JV, Roth JA, Wu X. MicroRNA-related genetic variants in iron regulatory genes, dietary iron intake, microRNAs and lung cancer risk. Ann Oncol 2018; 28:1124-1129. [PMID: 28453699 DOI: 10.1093/annonc/mdx046] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Background Genetic variations in MicroRNA (miRNA) binding sites may alter structural accessibility of miRNA binding sites to modulate risk of cancer. This large-scale integrative multistage study was aimed to evaluate the interplay of genetic variations in miRNA binding sites of iron regulatory pathway, dietary iron intake and lung cancer (LC) risk. Patients and methods The interplay of genetic variant, dietary iron intake and LC risk was assessed in large-scale case-control study. Functional characterization of the validated SNP and analysis of target miRNAs were performed. Results We found that the miRNA binding site SNP rs1062980 in 3' UTR of Iron-Responsive Element Binding protein 2 gene (IREB2) was associated with a 14% reduced LC risk (P value = 4.9×10 - 9). Comparing to AA genotype, GG genotype was associated with a 27% reduced LC risk. This association was evident in males and ever-smokers but not in females and never-smokers. Higher level of dietary iron intake was significantly associated with 39% reduced LC risk (P value = 2.0×10 - 8). This association was only present in individuals with AG + AA genotypes with a 46% reduced risk (P value = 1.0×10 - 10), but not in GG genotype. The eQTL-analysis showed that rs1062980 significantly alters IREB2 expression level. Rs1062980 is predicted to alter a miR-29 binding site on IREB2 and indeed the expression of miR-29 is inversely correlated with IREB2 expression. Further, we found that higher circulating miR-29a level was significantly associated with 78% increased LC risk. Conclusion The miRNA binding site SNP rs1062980 in iron regulatory pathway, which may alter the expression of IREB2 potentially through modulating the binding of miR-29a, together with dietary iron intake may modify risk of LC both individually and jointly. These discoveries reveal novel pathway for understanding lung cancer tumorigenesis and risk stratification.
Collapse
Affiliation(s)
- L Zhang
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA
| | - Y Ye
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA
| | - H Tu
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA
| | - M A Hildebrandt
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA
| | - L Zhao
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA.,Department of Radiation Oncology, The Forth Military Medical University, XiAn, China
| | - J V Heymach
- Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 2130 West Holcombe Boulevard, Houston, Texas 77030, USA
| | - J A Roth
- Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
| | - X Wu
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA
| |
Collapse
|
44
|
Kang J, Chen H, Zhang X, Zhou Q, Tu H, Yang J. P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Li Y, Jiang B, Yang J., Zhang X, Zhang Z, Zhou Q, Tu H, Wang Z, Chen H, Xu C, Wang B, Wu Y. JCES 01.26 Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
46
|
Wu Y, Tu H, Feng J, Shi M, Zhao J, Wang Y, Chang J, Wang J, Cheng Y, Zhu J, Tan E, Li K, Zhang Y, Lee V, Yang C, Su W, Lam C, Srinivasa B, Rajappa S, Ho C, Lam K, Hu Y, Bondarde S, Liu X, Fan J, Kuo D, Wang Y, Pang K, Zhou C. P3.01-036 A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1477] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
47
|
Li Y, Jiang B, Yang J, Zhang X, Zhang Z, Zhong W, Zhou Q, Tu H, Wang Z, Chen H, Xu C, Wang B, Wu Y. P1.01-010 Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Tu H, Sun P, Gu H, Zhang X, Huang H, Wan T, Liu J. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma. Eur J Surg Oncol 2017; 43:1768-1775. [DOI: 10.1016/j.ejso.2017.05.019] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2017] [Revised: 04/20/2017] [Accepted: 05/18/2017] [Indexed: 11/17/2022] Open
|
49
|
Jones D, Woyach JA, Zhao W, Caruthers S, Tu H, Coleman J, Byrd JC, Johnson AJ, Lozanski G. PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment. Leukemia 2017; 31:1645-1647. [PMID: 28366935 DOI: 10.1038/leu.2017.110] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- D Jones
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - J A Woyach
- Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - W Zhao
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - S Caruthers
- James Polaris Molecular Laboratory, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - H Tu
- James Polaris Molecular Laboratory, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - J Coleman
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - J C Byrd
- Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - A J Johnson
- Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| | - G Lozanski
- Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA
| |
Collapse
|
50
|
Lin W, Mou L, Tu H, Zhu L, Wang J, Chen J, Hu Y. Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients. J Clin Pharm Ther 2016; 42:122-124. [PMID: 27966241 DOI: 10.1111/jcpt.12485] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Accepted: 10/31/2016] [Indexed: 11/29/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Calcineurin inhibitor (CNI)-based immunosuppressive regimen is widely used for preventing rejection in solid organ transplantation. Hyperkalemic renal tubular acidosis (RTA) caused by CNI is uncommon and potentially underappreciated. We reported four such cases to increase awareness of this risk and to provide recommendations for its management based on our experience. CASE SUMMARY Four middle-aged males underwent solid organ transplant (two kidneys, one liver, one heart) and were treated with CNI-based immunosuppressive regimen (one cyclosporine A, three tacrolimus). On post-operative day 13-35, hyperkalemic hyperchloremic non-gap metabolic acidosis developed. All patients had relatively preserved renal function, normal urine output and plasma aldosterone level. Reduction in CNI dosage was partly effective; the patient on cyclosporine A was treated with fludrocortisone, and two others temporarily switched to sirolimus (SRL). WHAT IS NEW AND CONCLUSION We should alert for CNI-induced hyperkalemic RTA in transplant recipients. By CNI dosage reduction or adding low dose fludrocortisone, or temporarily switching to SRL, the prognosis of CNI-induced hyperkalemic RTA is favourable.
Collapse
Affiliation(s)
- W Lin
- Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - L Mou
- Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - H Tu
- Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - L Zhu
- Department of Nephrology, Binjiang Branch Hospital, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - J Wang
- Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - J Chen
- Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - Y Hu
- Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| |
Collapse
|